TP53 and neoplasm: Therefore, our results based on TP53-mutant Huh-7 cells also suggest that ALDH7A1 is conducive to tumor progression in TP53 mutant HCC, and the unknown TP53 status in the clinical samples may lead to the discrepant findings.